Macrophage-Muscle Precursor Cell Interaction in the Context of HIV Infection

HIV 感染背景下巨噬细胞-肌肉前体细胞的相互作用

基本信息

  • 批准号:
    7901067
  • 负责人:
  • 金额:
    $ 35.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-28 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human immunodeficiency virus (HIV) associated weight loss and muscle wasting remain significant clinical concerns even in the era of potent antiretroviral therapy. The pathogenic sequelae leading to HIV-associated muscle wasting are multi-factorial but can often be characterized by inflammatory muscle degeneration. While androgen supplementation increases muscle mass in treated subjects, significant side effects limit their long-term use. Therefore, there is a need to identify additional mechanisms that promote muscle regeneration. Muscle tissue contains resident muscle precursor cells (MFCs) that are critical in the myogenic regeneration capacity of muscle tissue in response to disuse, damage or atrophy. Notably, in addition to displaying responsiveness to growth promoting androgens, MFCs also release monocyte chemoattractants and require the presence of recruited monocytes / macrophages to repair damaged muscle in animal models. Paradoxically, stimulated macrophages can be pro-inflammatory, raising the possibility for a phenotype that contributes to muscle wasting, rather than promoting muscle growth. HIV infection may tip this balance. The overall objective of this proposal is to characterize the interplay between distinct modes of macrophage stimulation with MFC commitment and differentiation to better understand the conditions that facilitate myogenesis. We hypothesize that HIV infection may favor the emergence of a "classical" pro-inflammatory phenotype, rather than an "alternative" anti-inflammatory phenotype, thereby exacerbating muscle loss. We propose to evaluate the role of macrophage soluble mediators and HIV infection in myogenesis at the immunohistochemical (Aim 1), genomic / proteomic (Aim 2) and chromatin biochemistry (Aim 3) levels to precisely define the muscle genetic program and to distinguish muscle lineage commitment with atrophy signaling. To insure the success of this proposal, we have assembled a multidisciplinary team with expertise in endocrinology, muscle biology, molecular virology and genomics to study macrophage-muscle precursor cell interaction in the context of HIV infection.
描述(申请人提供):人类免疫缺陷病毒(HIV)相关的体重减轻和肌肉萎缩仍然是重要的临床问题,即使在有效的抗逆转录病毒治疗的时代也是如此。导致HIV相关肌肉萎缩的致病后遗症是多因素的,但通常以炎症性肌肉退化为特征。虽然雄激素补充增加了受试者的肌肉质量,但显著的副作用限制了它们的长期使用。因此,有必要确定促进肌肉再生的其他机制。肌肉组织含有驻留的肌肉前体细胞(MFC),它们在肌肉组织在废弃、损伤或萎缩时的肌源性再生能力中起着至关重要的作用。值得注意的是,除了表现出对促生长雄激素的反应性外,MFC还释放单核细胞趋化物质,并在动物模型中需要招募的单核/巨噬细胞来修复受损的肌肉。矛盾的是,受刺激的巨噬细胞可能是促炎的,增加了导致肌肉萎缩的表型的可能性,而不是促进肌肉生长。艾滋病毒感染可能会打破这种平衡。这项建议的总体目标是描述巨噬细胞刺激与MFC承诺和分化的不同模式之间的相互作用,以更好地了解促进肌肉发生的条件。我们推测,HIV感染可能有利于出现一种“经典”的促炎表型,而不是一种“替代”的抗炎表型,从而加剧肌肉损失。我们建议在免疫组织化学(AIM 1)、基因组/蛋白质组(AIM 2)和染色质生化(AIM 3)水平上评估巨噬细胞可溶性介质和HIV感染在肌肉发生中的作用,以准确定义肌肉遗传程序并区分肌肉谱系承诺和萎缩信号。为了确保这一提议的成功,我们组建了一个拥有内分泌学、肌肉生物学、分子病毒学和基因组学专业知识的多学科团队,以研究艾滋病毒感染背景下巨噬细胞-肌肉前体细胞的相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MONTY A MONTANO其他文献

MONTY A MONTANO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MONTY A MONTANO', 18)}}的其他基金

Biomarkers for Muscle Function and Aging in Chronic HIV Infection
慢性 HIV 感染中肌肉功能和衰老的生物标志物
  • 批准号:
    9269506
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
慢性 HIV 感染中肌肉功能和衰老的生物标志物
  • 批准号:
    8951764
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
慢性 HIV 感染中肌肉功能和衰老的生物标志物
  • 批准号:
    8853802
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Simultaneous latent HIV reactivation and cytokine gene suppression
同时潜伏的 HIV 重新激活和细胞因子基因抑制
  • 批准号:
    8701801
  • 财政年份:
    2013
  • 资助金额:
    $ 35.89万
  • 项目类别:
Macrophage-Muscle Precursor Cell Interaction in the Context of HIV Infection
HIV 感染背景下巨噬细胞-肌肉前体细胞的相互作用
  • 批准号:
    7647317
  • 财政年份:
    2007
  • 资助金额:
    $ 35.89万
  • 项目类别:
Macrophage-Muscle Precursor Cell Interaction in the Context of HIV Infection
HIV 感染背景下巨噬细胞-肌肉前体细胞的相互作用
  • 批准号:
    7339136
  • 财政年份:
    2007
  • 资助金额:
    $ 35.89万
  • 项目类别:
Macrophage-Muscle Precursor Cell Interaction in the Context of HIV Infection
HIV 感染背景下巨噬细胞-肌肉前体细胞的相互作用
  • 批准号:
    7490013
  • 财政年份:
    2007
  • 资助金额:
    $ 35.89万
  • 项目类别:
Macrophage-Muscle Precursor Cell Interaction in the Context of HIV Infection
HIV 感染背景下巨噬细胞-肌肉前体细胞的相互作用
  • 批准号:
    8101822
  • 财政年份:
    2007
  • 资助金额:
    $ 35.89万
  • 项目类别:
HIV and Aging SWG
艾滋病毒和老龄化 SWG
  • 批准号:
    10238753
  • 财政年份:
    2004
  • 资助金额:
    $ 35.89万
  • 项目类别:
Molecular Analysis of HIV-1C Transmission Cofactors
HIV-1C 传播辅助因子的分子分析
  • 批准号:
    6895343
  • 财政年份:
    2003
  • 资助金额:
    $ 35.89万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了